Because our data suggest that obesity and potentially other hyperglycemic diseases can both elevate OGT activity and drive a tumorigenic pathway in tumors, rising obesity rates [7] are concerning with respect to the pathway we put together here. The gene discussed is OGT; the disease is obesity due to melanocortin 4 receptor deficiency.